[Federal Register Volume 82, Number 244 (Thursday, December 21, 2017)]
[Notices]
[Pages 60608-60609]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-27482]



[[Page 60608]]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-18-0978; Docket No. CDC-2017-0116]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
Federal agencies the opportunity to comment on a proposed and/or 
continuing information collection, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on a proposed 
information collection project titled Emerging Infections Program, a 
population-based surveillance via active, laboratory case finding that 
is used for detecting, identifying, and monitoring emerging pathogens.

DATES: CDC must receive written comments on or before February 20, 
2018.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2017-
0116 by any of the following methods:
     Federal eRulemaking Portal: Regulations.gov. Follow the 
instructions for submitting comments.
     Mail: Leroy A. Richardson, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS-D74, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to Regulations.gov.
    Please note: Submit all Federal comments through the Federal 
eRulemaking portal (regulations.gov) or by U.S. mail to the address 
listed above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Leroy A. Richardson, Information Collection 
Review Office, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: 
[email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
Federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected; and
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses.
    5. Assess information collection costs.

Proposed Project

    Emerging Infections Program (OMB Control Number 0920-0978, 
Expiration Date 2/28/2019)--Revision--National Center for Emerging and 
Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and 
Prevention (CDC).

Background and Brief Description

    The Emerging Infections Programs (EIPs) are population-based 
centers of excellence established through a network of state health 
departments collaborating with academic institutions; local health 
departments; public health and clinical laboratories; infection control 
professionals; and healthcare providers. EIPs assist in local, state, 
and national efforts to prevent, control, and monitor the public health 
impact of infectious diseases.
    Activities of the EIPs fall into the following general categories: 
(1) Active surveillance; (2) applied public health epidemiologic and 
laboratory activities; (3) implementation and evaluation of pilot 
prevention/intervention projects; and (4) flexible response to public 
health emergencies. Activities of the EIPs are designed to: (1) Address 
issues that the EIP network is particularly suited to investigate; (2) 
maintain sufficient flexibility for emergency response and new problems 
as they arise; (3) develop and evaluate public health interventions to 
inform public health policy and treatment guidelines; (4) incorporate 
training as a key function; and (5) prioritize projects that lead 
directly to the prevention of disease.
    A revision is being submitted to make existing forms clearer and to 
add several new forms: ABCs Severe GAS Infection Supplemental Form, 
HAIC Multi-site Gram-Negative Bacilli Case Report Form for Carbapenem-
resistant Pseudomonas aeruginosa (CR-PA), HAIC Multi-site Gram-Negative 
Surveillance Initiative--Extended-Spectrum Beta-Lactamase-Producing 
Enterobacteriaceae (MuGSI-ESBL), HAIC Invasive Methicillin-sensitive 
Staphylococcus aureus (MSSA), and HAIC Candidemia Case Report Form. 
These forms will allow the EIP to better detect, identify, and monitor 
emerging pathogens. The estimates of the infection incidence generated 
by this collection provide the foundation for a variety of 
epidemiologic studies to explore risk factors, spectrum of disease, and 
prevention strategies.
    The total estimated burden is 40,347 hours. There is no cost to 
respondents other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                            Number of     Average
                                                               Number of    responses    burden per     Total
         Type of respondents                 Form name        respondents      per        response   burden  (in
                                                                            respondent   (in hours)     hours)
----------------------------------------------------------------------------------------------------------------
State Health Department.............  ABCs Case Report Form.           10          809        20/60        2,697

[[Page 60609]]

 
                                      ABCs Invasive                    10           22        10/60           37
                                       Pneumococcal Disease
                                       in Children Case
                                       Report Form.
                                      ABCs Surveillance for            10          125        10/60          208
                                       Non-Invasive
                                       Pneumococcal
                                       Pneumonia (SNiPP)
                                       Case Report Form.
                                      ABCs H.influenzae                10            6        10/60           10
                                       Neonatal Sepsis
                                       Expanded Surveillance
                                       Form.
                                      ABCs Severe GAS                  10          136        20/60          453
                                       Infection
                                       Supplemental Form--
                                       NEW FORM.
                                      ABCs Neonatal                    10           37        20/60          123
                                       Infection Expanded
                                       Tracking Form.
                                      FoodNet Campylobacter.           10          850        21/60        2,975
                                      FoodNet                          10          130        10/60          217
                                       Cryptosporidium.
                                      FoodNet Cyclospora....           10            3        10/60            5
                                      FoodNet Listeria                 10           13        20/60           43
                                       monocytogenes.
                                      FoodNet Salmonella....           10          827        21/60        2,895
                                      FoodNet Shiga toxin              10          190        20/60          633
                                       producing E. coli.
                                      FoodNet Shigella......           10          290        10/60          483
                                      FoodNet Vibrio........           10           25        10/60           42
                                      FoodNet Yersinia......           10           30        10/60           50
                                      FoodNet Hemolytic                10           10            1          100
                                       Uremic Syndrome.
                                      Influenza                        10        1,000        25/60        4,167
                                       Hospitalization
                                       Surveillance Network
                                       Case Report Form.
                                      Influenza                        10          333         5/60          278
                                       Hospitalization
                                       Surveillance Project
                                       Vaccination Phone
                                       Script Consent Form
                                       (English).
                                      Influenza                        10          333         5/60          278
                                       Hospitalization
                                       Surveillance Project
                                       Vaccination Phone
                                       Script Consent Form
                                       (Spanish).
                                      Influenza                        10          333         5/60          278
                                       Hospitalization
                                       Surveillance Project
                                       Provider Vaccination
                                       History Fax Form
                                       (Children/Adults).
                                      HAIC CDI Case Report             10        1,650        30/60        8,250
                                       Form.
                                      HAIC Multi-site Gram-            10          500        20/60        1,667
                                       Negative Bacilli Case
                                       Report Form (MuGSI-
                                       CRE/CRAB).
                                      HAIC Multi-site Gram-            10          344        45/60        2,580
                                       Negative Bacilli Case
                                       Report Form for
                                       Carbapenem-resistant
                                       Pseudomonas
                                       aeruginosa(CR-PA)--NE
                                       W FORM.
                                      HAIC Multi-site Gram-            10        1,200        20/60        4,000
                                       Negative Surveillance
                                       Initiative--Extended-
                                       Spectrum Beta-
                                       Lactamase-Producing
                                       Enterobacteriaceae
                                       (MuGSI-ESBL)--NEW
                                       FORM.
                                      HAIC Invasive                    10          609        20/60        2,030
                                       Methicillin-resistant
                                       Staphylococcus aureus
                                       (MRSA).
                                      HAIC Invasive                    10        1,035        20/60        3,450
                                       Methicillin-sensitive
                                       Staphylococcus aureus
                                       (MSSA)--NEW FORM.
                                      HAIC Candidemia Case              9          800        20/60        2,400
                                       Report Form--NEW FORM.
                                                             ---------------------------------------------------
    Total...........................  ......................  ...........  ...........  ...........       40,347
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2017-27482 Filed 12-20-17; 8:45 am]
 BILLING CODE 4163-18-P